沙培林碘化油乳剂治疗原发性肝癌的中远期疗效分析  

The mid to long term therapeutic efficacy of Sapylin-lipiodol emulsion in treating patients with hepatocellular carcinoma

作　　者：杨辉 李鹤平[2] 张冰[2] 杨建勇[2] 刘锦召 许卫国[3] 

机构地区：[1]深圳市龙岗区平湖人民医院放射科,广东518111 [2]中山大学附属第一医院介入放射科,510080 [3]珠海市人民医院放射科,519000

出　　处：《当代医学》2011年第14期48-49,共2页Contemporary Medicine

基　　金：国家自然科学基金项目;编号:30600156;30870692;81071247;广东省社会发展领域科技计划项目;编号:1011211500198

摘　　要：目的探讨沙培林碘化油乳剂治疗原发性肝癌的中远期疗效。方法对110例原发性肝癌患者分实验组及对照组,分别进行沙培林TACE治疗及常规TACE治疗,对术后1年、3年、5年的生存率进行对比分析。结果 实验组在术后1年、3年、5年的生存率上均优于对照组。结论沙培林碘化油乳剂免疫栓塞显示出较好的中远期疗效。Objective To analyze the value of transarterial immunoembolization with an emulsion of streptococcal agent Sapylin and lipiodol in treating patients with hepatocellular carcinoma.Methods： 110 patients with hepatocellular carcinoma were divided into two groups： test group and control group.Test group were cured with the streptococcal agent Sapylin and lipiodol,Control group were cured with the common chemical drug and lipiodol.The difference of the curative effect after the treatment was studied.Results： The effect of treatment,survivial rate of test group after transarterial chemoembolization were better than those of control group.Conclusion： It is a safe and feasible therapeutic modality that transarterial immunoembolization with an emulsion of streptococcal agent Sapylin and lipiodol in treating patients with hepatocellular carcinoma.

关 键 词：沙培林 原发性肝癌 经导管动脉化疗栓塞 

分 类 号：R735.7[医药卫生—肿瘤]